General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0AVFVQ
ADC Name
cBR96-ADC-24-13
Synonyms
cBR96 ADC 24 13
   Click to Show/Hide
Organization
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Small cell lung cancer [ICD11:2C25]
Investigative
Drug-to-Antibody Ratio
4-8
Structure
Antibody Name
Anti-Lewis-Y mAb cBR96
 Antibody Info 
Antigen Name
Lewis Y
 Antigen Info 
Payload Name
Undisclosed
Linker Name
cBR96-ADC-24-13 linker

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.